General Information
Version
1.0
Revision date
2023-04-13
Product name
207/GP101 - GRAFFITI & FLYPOSTING PROTECTION SYSTEM
supplier name
Coo-Var
Emergency telephone
+44 (0) 1482 328053
Icons in SDS
Company Information
company name
Coo-Var
e-mail address of the competent person responsible for the Safety Data Sheet
info@coo-var.co.uk
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H226, H317, H336
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Flammable liquid and vapour. May cause drowsiness or dizziness. May cause an allergic skin reaction.
2.2 Label elements
Labelling
Hazard pictograms
GHS02 GHS07
Signal word
Warning
Contains
Silane Reaction Product; Amino-Silane; Hydrocarbons, C9-C11, n-alkanes, isoalkanes, cyclics, <2% aromatics Amino-Saline. May produce an allergic reaction
Hazard statements
H226 - Flammable liquid and vapour. H317 - May cause an allergic skin reaction. H336 - May cause drowsiness or dizziness.
Precautionary statements
P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P303+P361+P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water/shower. P370+P378 - In case of fire: Use media other than water to extinguish. P403+P233 - Store in a well-ventilated place. Keep container tightly closed. P403+P235 - Store in a well-ventilated place. Keep cool. P405 - Store locked up. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %